Header Logo

Connection

CHRISTIE BALLANTYNE to RNA Interference

Back to Details
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about RNA Interference.
CHRISTIE BALLANTYNE
Connection Strength
0.435
RNA Interference
  1. RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evid. 2023 12; 2(12):EVIDoa2200325.
    View in: PubMed
    Score: 0.183
  2. RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. Nat Med. 2023 09; 29(9):2216-2223.
    View in: PubMed
    Score: 0.180
  3. Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective. Cardiovasc Drugs Ther. 2021 12; 35(6):1269-1279.
    View in: PubMed
    Score: 0.037
  4. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions. Curr Atheroscler Rep. 2020 06 03; 22(7):25.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.